» Articles » PMID: 15202072

Large-scale Single-nucleotide Polymorphism (SNP) and Haplotype Analyses, Using Dense SNP Maps, of 199 Drug-related Genes in 752 Subjects: the Analysis of the Association Between Uncommon SNPs Within Haplotype Blocks and the Haplotypes Constructed...

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2004 Jun 18
PMID 15202072
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

To optimize the strategies for population-based pharmacogenetic studies, we extensively analyzed single-nucleotide polymorphisms (SNPs) and haplotypes in 199 drug-related genes, through use of 4,190 SNPs in 752 control subjects. Drug-related genes, like other genes, have a haplotype-block structure, and a few haplotype-tagging SNPs (htSNPs) could represent most of the major haplotypes constructed with common SNPs in a block. Because our data included 860 uncommon (frequency <0.1) SNPs with frequencies that were accurately estimated, we analyzed the relationship between haplotypes and uncommon SNPs within the blocks (549 SNPs). We inferred haplotype frequencies through use of the data from all htSNPs and one of the uncommon SNPs within a block and calculated four joint probabilities for the haplotypes. We show that, irrespective of the minor-allele frequency of an uncommon SNP, the majority (mean +/- SD frequency 0.943+/-0.117) of the minor alleles were assigned to a single haplotype tagged by htSNPs if the uncommon SNP was within the block. These results support the hypothesis that recombinations occur only infrequently within blocks. The proportion of a single haplotype tagged by htSNPs to which the minor alleles of an uncommon SNP were assigned was positively correlated with the minor-allele frequency when the frequency was <0.03 (P<.000001; n=233 [Spearman's rank correlation coefficient]). The results of simulation studies suggested that haplotype analysis using htSNPs may be useful in the detection of uncommon SNPs associated with phenotypes if the frequencies of the SNPs are higher in affected than in control populations, the SNPs are within the blocks, and the frequencies of the SNPs are >0.03.

Citing Articles

In-silico assessment of high-risk non-synonymous SNPs in ADAMTS3 gene associated with Hennekam syndrome and their impact on protein stability and function.

Shinwari K, Wu Y, Rehman H, Xiao N, Bolkov M, Tuzankina I BMC Bioinformatics. 2023; 24(1):251.

PMID: 37322437 PMC: 10268432. DOI: 10.1186/s12859-023-05361-6.


Evaluation of low-density SNP panels and imputation for cost-effective genomic selection in four aquaculture species.

Kriaridou C, Tsairidou S, Fraslin C, Gorjanc G, Looseley M, Johnston I Front Genet. 2023; 14:1194266.

PMID: 37252666 PMC: 10213886. DOI: 10.3389/fgene.2023.1194266.


Novel Disease-Associated Missense Single-Nucleotide Polymorphisms Variants Predication by Algorithms Tools and Molecular Dynamics Simulation of Human TCIRG1 Gene Causing Congenital Neutropenia and Osteopetrosis.

Shinwari K, Rehman H, Liu G, Bolkov M, Tuzankina I, Chereshnev V Front Mol Biosci. 2022; 9:879875.

PMID: 35573728 PMC: 9095858. DOI: 10.3389/fmolb.2022.879875.


Predicting the Most Deleterious Missense Nonsynonymous Single-Nucleotide Polymorphisms of Hennekam Syndrome-Causing CCBE1 Gene, In Silico Analysis.

Shinwari K, Guojun L, Deryabina S, Bolkov M, Tuzankina I, Chereshnev V ScientificWorldJournal. 2021; 2021:6642626.

PMID: 34234628 PMC: 8211529. DOI: 10.1155/2021/6642626.


Computational determination of human PPARG gene: SNPs and prediction of their effect on protein functions of diabetic patients.

Mustafa H, Albkrye A, AbdAlla B, Khair M, Abdelwahid N, Elnasri H Clin Transl Med. 2020; 9(1):7.

PMID: 32064572 PMC: 7024687. DOI: 10.1186/s40169-020-0258-1.


References
1.
Smigielski E, Sirotkin K, Ward M, Sherry S . dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 1999; 28(1):352-5. PMC: 102496. DOI: 10.1093/nar/28.1.352. View

2.
Evans W, Relling M . Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999; 286(5439):487-91. DOI: 10.1126/science.286.5439.487. View

3.
Kwiatkowski R, Lyamichev V, de Arruda M, Neri B . Clinical, genetic, and pharmacogenetic applications of the Invader assay. Mol Diagn. 2000; 4(4):353-64. DOI: 10.1016/s1084-8592(99)80012-5. View

4.
Drysdale C, McGraw D, Stack C, Stephens J, Judson R, Nandabalan K . Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A. 2000; 97(19):10483-8. PMC: 27050. DOI: 10.1073/pnas.97.19.10483. View

5.
Oda N, Cox N, Li X, Orho-Melander M, Hara M, Hinokio Y . Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000; 26(2):163-75. DOI: 10.1038/79876. View